The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer said in a news release. The drug is expected to be available in pharmacies in July 2023, the company said. There are already a number of different types of medications available to treat migraines, including several kinds of nasal sprays.
In one study published in the journal The Lancet Neurology, about 24% of people who took a single 10 milligram dose of Zavzpret reported they had no pain two hours later, compared with 15% of the group who got a nasal spray without any active ingredients, a difference that was statistically significant. The main side effect reported in the study was an altered sense of taste, which affected about 1 in 5 people who took the drug. Other side effects were nasal discomfort and nausea.
Who trusts the FDA Really?!
Probably with mRNa vaccine in it. Be aware that they can do it, and they will.
… out of curiosity do you still trust Pfizer for things you inhale, inject or swallow?
What about figuring out what causes migraines in the first place as opposed to loading your body up more drugs with unknown side affects.
Pfizer can Pfuckoff
Prevent migraines with Botox. It has vastly improved my quality of life.
FakeNews only 26% trust you 🤪😂😂
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: ABC - 🏆 471. / 51 Read more »